Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Pediatric Neurology · Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum

Building Your Care Team and Preparing for Visits

At a Glance

Children with H-ABC benefit from coordinated care led by a pediatric neurologist or genetics specialist, with support from movement, therapy, feeding, orthopedic, breathing, and vision teams. Bring original MRI images, the complete TUBB4A genetic report, and a symptom timeline before visits.

Building a care team for a rare condition like H-ABC can feel like assembling a specialized team. Because this condition affects movement, development, and basic functions like swallowing and breathing, your child will need a multidisciplinary team—a group of different specialists who work together to treat the “whole child” rather than just one symptom [1][2].

The Core Medical Team

At the center of your child’s care should be a specialist with deep experience in leukodystrophies (white matter diseases). High-quality centers often provide a “hub” where several of these experts practice together [3][4]:

  • Pediatric Neurologist or Neurogeneticist: This is your primary team member. They interpret the genetic data and coordinate the overall medical strategy [5][6].
  • Movement Disorder Specialist: A neurologist who focuses specifically on dystonia, spasticity, and ataxia. They are essential for fine-tuning medications and interventions for movement challenges [7][8].
  • Physical, Occupational, and Speech Therapists: These specialists work directly with you to maintain mobility, adapt your home environment, and assist with communication [7][9].
  • Gastroenterology (GI) and Nutrition Specialist: They monitor growth, reflux, and tube feeding, while the speech-language pathologist assesses whether your child is swallowing safely [7][10].
  • Orthopedic Surgeon: They track bone and joint health, specifically watching for spine curvature (scoliosis) or hip displacement [7].
  • Pulmonologist: As the disease progresses, they monitor lung health and sleep-related breathing issues [1].
  • Neuro-Ophthalmologist: Visual dysfunction like nystagmus (shaking eyes) or optic nerve changes can occur in leukodystrophies. An age-appropriate vision assessment or specialist referral is recommended based on symptoms [11].

Preparing for Your First Specialty Visit

When you visit a specialized leukodystrophy center, the doctors need more than just a summary; they need the raw data. Collecting these “artifacts” beforehand is one of the most powerful things you can do as an advocate [12][13].

  • Imaging Disks (DICOM files): Do not rely on written radiology reports alone. Request the original brain MRI images on a disk or via a secure digital link from every facility where your child has had a scan. Specialists need to see the “pictures” side-by-side to judge how the basal ganglia and cerebellum are changing over time [14][15].
  • Complete Genetic Reports: Bring the full multi-page report from the testing lab. It contains technical details about the specific TUBB4A variant (like the “nucleotide change”) that are critical for understanding your child’s specific prognosis and trial eligibility [5][16].
  • A “Diagnostic Odyssey” Timeline: Write down a simple history of when symptoms started, which milestones were reached (and when), and any medications your child has already tried. This helps the team see the “trajectory” of the condition [12][7].

What Makes a “Center of Excellence”?

Research shows that patients treated at specialized leukodystrophy centers are more likely to receive accurate, timely diagnoses and coordinated care [3]. If you cannot access a center in person, many local pediatric teams can work collaboratively through remote expert consultations. When vetting a team, look for these features:

  1. Care Coordination: Is there a dedicated nurse or coordinator who helps schedule your appointments so you can see multiple specialists in one or two days? [4][17]
  2. Research Integration: Check with reputable organizations to see if the center participates in natural history studies or registries. This ensures your child’s data helps advance future treatments [6][5].
  3. Standardized Tracking: A specialist team may use tools like the GMFM-88 for movement or CPCHILD for quality of life. While developed for cerebral palsy and not validated specifically for H-ABC, these are examples of how clinicians might objectively measure your child’s progress over the years [18][9].

By gathering the right data and the right experts, you move from a place of uncertainty to a proactive plan for your child’s future [1][2].

Common questions in this guide

Which specialists should care for a child with H-ABC?
Care is usually coordinated by a pediatric neurologist or neurogeneticist with leukodystrophy experience. Depending on the child's needs, the team may also include a movement-disorder specialist, physical, occupational, and speech therapists, gastrointestinal and nutrition clinicians, an orthopedic surgeon, pulmonologist, and neuro-ophthalmologist.
What should I bring to an H-ABC specialist appointment?
Bring the original brain MRI image files, not only written reports; the full genetic laboratory report with the TUBB4A variant details; and a timeline of symptoms, milestones, and medications. Videos of important movements can also help explain changes that may not appear during a short visit.
Why do specialists need the original MRI images?
The original images let the team review scans from different facilities side by side and look for changes in the basal ganglia and cerebellum over time. A written radiology report alone may not show every detail the specialist needs for assessment.
How can I tell if a leukodystrophy center is right for my child?
Look for a team that coordinates multiple appointments, works with local clinicians, and offers remote expert consultation when travel is difficult. Participation in natural history studies or registries and consistent tracking of movement and quality of life can also be useful.
How are dystonia and spasticity addressed in H-ABC?
A movement-disorder specialist can assess dystonia, spasticity, and ataxia and help adjust medicines or other interventions. Physical, occupational, and speech therapists can support mobility, daily activities, communication, and safe swallowing as part of an individualized plan.
How can our local therapists work with the H-ABC specialty team?
Ask the specialty team to share findings and recommendations with your child's local physical and occupational therapists and other providers. A shared plan can help align exercises, home adaptations, communication support, and daily care with your child's current needs.

Get notified when new evidence is published on Hypomyelination with atrophy of basal ganglia and cerebellum.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    POLR3-Related Leukodystrophy: A Qualitative Study on Parents' Experiences With the Health Care System.

    Le A, Thibault KA, Yazdani PA, et al.

    Pediatric neurology 2025; (166()):81-87 doi:10.1016/j.pediatrneurol.2025.02.011.

    PMID: 40106878
  2. 2

    Impact of Interdisciplinary Team Care for Children With 22q11.2 Deletion Syndrome.

    Hickey SE, Kellogg B, O'Brien M, et al.

    The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2020; (57(12)):1362-1369 doi:10.1177/1055665620947985.

    PMID: 32787583
  3. 3

    Geographic and Specialty Access Disparities in US Pediatric Leukodystrophy Diagnosis.

    Grineski S, Morales DX, Collins T, et al.

    The Journal of pediatrics 2020; (220()):193-199 doi:10.1016/j.jpeds.2020.01.063.

    PMID: 32143930
  4. 4

    An Integrated Care Strategy for Pre-schoolers with Suspected Developmental Disorders: The Optimus Co-design Project that has Made it to Regular Care.

    Sarkadi A, Dahlberg A, Leander K, et al.

    International journal of integrated care 2021; (21(2)):3 doi:10.5334/ijic.5494.

    PMID: 33953649
  5. 5

    Update on leukodystrophies and developing trials.

    Ceravolo G, Zhelcheska K, Squadrito V, et al.

    Journal of neurology 2024; (271(1)):593-605 doi:10.1007/s00415-023-11996-5.

    PMID: 37755460
  6. 6

    Rigorous genetic diagnosis review in natural history studies.

    Pizzino A, Arnold K, Wiener E, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 42050713
  7. 7

    The natural history of variable subtypes in pediatric-onset TUBB4A-related leukodystrophy.

    Gavazzi F, Charsar B, Hamilton E, et al.

    Molecular genetics and metabolism 2025; (144(3)):109048 doi:10.1016/j.ymgme.2025.109048.

    PMID: 39951964
  8. 8

    Deep brain stimulation in an adolescent with hypomyelination with atrophy of the basal ganglia and cerebellum due to a TUBB4A mutation: illustrative case.

    MacLean JA, Nataraj J, Olaya J, et al.

    Journal of neurosurgery. Case lessons 2023; (6(2)).

    PMID: 37458337
  9. 9

    Gross Motor Function in Pediatric Onset TUBB4A-Related Leukodystrophy: GMFM-88 Performance and Validation of GMFC-MLD in TUBB4A.

    Gavazzi F, Patel V, Charsar B, et al.

    Journal of child neurology 2023; (38(8-9)):498-504 doi:10.1177/08830738231188159.

    PMID: 37461315
  10. 10

    Gut dysmotility in children with neurological impairment: the nutritional management.

    Corsello A, Scatigno L, Govoni A, et al.

    Frontiers in neurology 2023; (14()):1200101 doi:10.3389/fneur.2023.1200101.

    PMID: 37213895
  11. 11

    Overview of Neuro-Ophthalmic Findings in Leukodystrophies.

    Bettinger CM, Dulz S, Atiskova Y, et al.

    Journal of clinical medicine 2024; (13(17)) doi:10.3390/jcm13175114.

    PMID: 39274327
  12. 12

    Epidemiological, clinical, and genetic characteristics of paediatric genetic white matter disorders in Northern Finland.

    Knuutinen OA, Oikarainen JH, Suo-Palosaari MH, et al.

    Developmental medicine and child neurology 2021; (63(9)):1066-1074 doi:10.1111/dmcn.14884.

    PMID: 33948933
  13. 13

    An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.

    Ashrafi MR, Amanat M, Garshasbi M, et al.

    Expert review of neurotherapeutics 2020; (20(1)):65-84 doi:10.1080/14737175.2020.1699060.

    PMID: 31829048
  14. 14

    MRI pattern recognition in white matter disease.

    Wolf NI, Engelen M, van der Knaap MS

    Handbook of clinical neurology 2024; (204()):37-50 doi:10.1016/B978-0-323-99209-1.00019-3.

    PMID: 39322391
  15. 15

    T2-Pseudonormalization and Microstructural Characterization in Advanced Stages of Late-infantile Metachromatic Leukodystrophy.

    Martin P, Hagberg GE, Schultz T, et al.

    Clinical neuroradiology 2021; (31(4)):969-980 doi:10.1007/s00062-020-00975-2.

    PMID: 33226437
  16. 16

    In-silico phenotype prediction by normal mode variant analysis in TUBB4A-related disease.

    Fellner A, Goldberg Y, Lev D, et al.

    Scientific reports 2022; (12(1)):58 doi:10.1038/s41598-021-04337-x.

    PMID: 34997144
  17. 17

    Spina bifida transition care in India: strengths amidst challenges.

    Udayakumaran S, Manda VV, Kedia S, et al.

    Neurosurgical focus 2024; (57(2)):E5 doi:10.3171/2024.6.FOCUS24266.

    PMID: 39088854
  18. 18

    Critical Functional Domains in Pediatric Onset TUBB4A-Related Leukodystrophy: A Clinical and Caregiver's Perspective.

    Gavazzi F, Patel V, Erler JA, et al.

    Pediatric neurology 2025; (173()):156-165 doi:10.1016/j.pediatrneurol.2025.09.019.

    PMID: 41129987

This page offers educational information about organizing care for a child with H-ABC and does not replace medical advice. Your child's specialists should tailor evaluations, treatments, and support services to your child's needs.